Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

NCT07007273 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT07007273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07007273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
June 20, 2025
Completion date
July 31, 2030
Enrollment
17 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous sarcoma